Literature DB >> 25384125

Improvement of memory impairments in poststroke patients by hyperbaric oxygen therapy.

Rahav Boussi-Gross1, Haim Golan2, Olga Volkov2, Yair Bechor1, Dan Hoofien3, Michal Schnaider Beeri4, Eshel Ben-Jacob5, Shai Efrati6.   

Abstract

OBJECTIVE: Several recent studies have shown that hyperbaric oxygen (HBO₂) therapy carry cognitive and motor therapeutic effects for patients with acquired brain injuries. The goal of this study was to address the specific effects of HBO₂ on memory impairments after stroke at late chronic stages.
METHOD: A retrospective analysis was conducted on data of 91 stroke patients 18 years or older (mean age ∼60 years) who had either ischemic or hemorrhagic stroke 3-180 months before HBO₂ therapy (M = 30-35 months). The HBO₂ protocol included 40 to 60 daily sessions, 5 days per week, 90 min each, 100% oxygen at 2ATA, and memory tests were administered before and after HBO₂ therapy using NeuroTrax's computerized testing battery. Assessments were based on verbal or nonverbal, immediate or delayed memory measures. The cognitive tests were compared with changes in the brain metabolic state measured by single-photon emission computed tomography.
RESULTS: Results revealed statistically significant improvements (p < .0005, effect sizes medium to large) in all memory measures after HBO₂ treatments. The clinical improvements were well correlated with improvement in brain metabolism, mainly in temporal areas.
CONCLUSIONS: Although further research is needed, the results illustrate the potential of HBO₂ for improving memory impairments in poststroke patients, even years after the acute event. (c) 2015 APA, all rights reserved).

Entities:  

Mesh:

Year:  2014        PMID: 25384125     DOI: 10.1037/neu0000149

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  26 in total

1.  Hyperbaric oxygen treatment in recurrent development of complex regional pain syndrome: A case report.

Authors:  Michal Hájek; Dittmar Chmelar; Jakub Tlapák; František Novomeský; Veronika Rybárová; Miloslav Klugar
Journal:  Diving Hyperb Med       Date:  2021-03-31       Impact factor: 0.887

2.  Hyperbaric oxygen therapy can diminish fibromyalgia syndrome--prospective clinical trial.

Authors:  Shai Efrati; Haim Golan; Yair Bechor; Yifat Faran; Shir Daphna-Tekoah; Gal Sekler; Gregori Fishlev; Jacob N Ablin; Jacob Bergan; Olga Volkov; Mony Friedman; Eshel Ben-Jacob; Dan Buskila
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

3.  Delayed recompression for decompression sickness: retrospective analysis.

Authors:  Amir Hadanny; Gregori Fishlev; Yair Bechor; Jacob Bergan; Mony Friedman; Amit Maliar; Shai Efrati
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

4.  Hyperbaric oxygen can induce neuroplasticity and improve cognitive functions of patients suffering from anoxic brain damage.

Authors:  A Hadanny; H Golan; G Fishlev; Y Bechor; O Volkov; G Suzin; E Ben-Jacob; S Efrati
Journal:  Restor Neurol Neurosci       Date:  2015       Impact factor: 2.406

5.  Hyperbaric oxygen increases tissue-plasminogen activator-induced thrombolysis in vitro, and reduces ischemic brain damage and edema in rats subjected to thromboembolic brain ischemia.

Authors:  Laurent Chazalviel; Benoit Haelewyn; Mickael Degoulet; Jean-Eric Blatteau; Nicolas Vallée; Jean-Jacques Risso; Stéphane Besnard; Jacques H Abraini
Journal:  Med Gas Res       Date:  2016-07-11

Review 6.  Hyperbaric oxygen therapy and preconditioning for ischemic and hemorrhagic stroke.

Authors:  Sheng-Li Hu; Hua Feng; Guo-Hua Xi
Journal:  Med Gas Res       Date:  2016-12-30

7.  Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife.

Authors:  Irit Cohen-Manheim; Glen M Doniger; Ronit Sinnreich; Ely S Simon; Ronit Pinchas-Mizrachi; James D Otvos; Jeremy D Kark
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

8.  Oxygen--a limiting factor for brain recovery.

Authors:  Amir Hadanny; Shai Efrati
Journal:  Crit Care       Date:  2015-09-01       Impact factor: 9.097

9.  Brain perfusion imaging with voxel-based analysis in secondary progressive multiple sclerosis patients with a moderate to severe stage of disease: a boon for the workforce.

Authors:  Mina Taghizadeh Asl; Reza Nemati; Negar Chabi; Hooman Salimipour; Iraj Nabipour; Majid Assadi
Journal:  BMC Neurol       Date:  2016-05-26       Impact factor: 2.474

10.  The efficacy of hyperbaric oxygen in hemorrhagic stroke: experimental and clinical implications.

Authors:  Robert P Ostrowski; Katarzyna Stępień; Emanuela Pucko; Ewa Matyja
Journal:  Arch Med Sci       Date:  2017-01-13       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.